SCHEMBL4883561

SCHEMBL4883561

CNCCC(c1ccc(Cl)cc1)c1ccc(Cl)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.67
HRH1 P35367 2/20 0.67
SLC6A4 P31645 7/20 0.54
CNR1 P21554 2/20 0.50
TAAR1 Q96RJ0 1/20 0.50
SLC6A2 P23975 3/20 0.47
SLC6A3 Q01959 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
NOS2 P35228 1/20 0.45
CASR P41180 1/20 0.45
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
MAPT P10636 1/20 0.45
CYP2C9 P11712 1/20 0.45
ALOX12 P18054 1/20 0.45
CYP2C19 P33261 1/20 0.45
HTT P42858 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1977932 0.91 HTR2A (0.56) HTR2AHRH1SLC6A4CNR1TAAR1
SCHEMBL3638413 0.80 HTR2A (1.00) HTR2AHRH1SLC6A4CNR1SLC6A2
SCHEMBL10845042 0.80 GAA (0.56) HTR2AHRH1SLC6A4TAAR1SLC6A2
SCHEMBL386863 0.80 SLC6A4 (0.47) HTR2AHRH1SLC6A4TAAR1SLC6A2
SCHEMBL19399097 0.80 GAA (0.56) HTR2AHRH1SLC6A4TAAR1SLC6A2
SCHEMBL16649689 0.80 SLC6A4 (0.47) HTR2AHRH1SLC6A4TAAR1SLC6A2
SCHEMBL22957651 0.80 GAA (0.56) HTR2AHRH1SLC6A4TAAR1SLC6A2
SCHEMBL2303674 0.80 SLC6A4 (0.64) HTR2AHRH1SLC6A4CNR1SLC6A2
SCHEMBL1978888 0.80 AKT2 (0.65) HTR2AHRH1
SCHEMBL8583011 0.79 HRH1 (0.67) HTR2AHRH1SLC6A4SLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1933832-A2 PHARMACEUTICAL COMBINATIONS COMPRISING PYRAZOLE DERIVATIVES AS PROTEIN KINASE MODULATORS Astex Therapeutics Limited (GB) 2008-06-25 EP disclosed
WO-2006136837-A2 PHARMACEUTICAL COMBINATIONS COMPRISING PYRAZOLE DERIVATIVES AS PROTEIN KINASE MODULATORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 WO disclosed